ICL Group Ltd
NYSE:ICLAgricultural Inputs
-$0.08 today
- Market cap
- $5.41B
- Beta
- 0.95
- P/E (TTM)
- 25.6
- EPS (TTM)
- $0.20
- Dividend yield
- 0.04%
Volume 1.71M
Average 1.48M
ICL Net Income
Bottom-line profit, the starting point for calculating cash from operations.
ICL Group LtdNYSE: ICL
Net Income · Q3 FY2026 · quarter ended Sep 2026
Net income growth accelerates
Q3 FY2026 net income of $129M rose 0.0% year over year, ahead of the -19.1% change in trailing-twelve-month net income. Sequentially, it fell 15.1% from the prior quarter. Over 3 fiscal years it compounded at -53.3% a year.
Context
- Net income amounted to 3.2% of revenue in FY2025, down 2.8 pp from a year earlier.
- Net income increased in 0 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether net income reaches the consensus estimate from 2 analysts of $529M (+134.1%) for the fiscal year ending Dec 2026, a step up from the -44.5% reported in FY2025.
Sources:Cash Flow Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterSep 2026
- $129M-15.1% QoQ
- Last fiscal yearDec 2025
- $226M-44.5% YoY
- LTMSep 2026
- $334M-19.1% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +0.0% | +248.1% | +248.1 pp |
| 1 year | -44.5% | +134.1% | +178.5 pp |
| 3-year CAGR | -53.3% | +40.5% | +93.8 pp |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Net Income history
USD · from the cash flow
- Latest · FY2025
- 226M USD
- Year-over-year change
- -44.5%
- 4-year CAGR
- -27.8%
| Period | Period end | Net Income | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 226M | -44.5% |
| FY2024 | 2024-12-31 | 407M | -37.1% |
| FY2023 | 2023-12-31 | 647M | -70.8% |
| FY2022 | 2022-12-31 | 2.22B | +166.7% |
| FY2021 | 2021-12-31 | 832M | — |
Net Income vs competitors
How ICL compares with its peers on the latest reported figures
No competitor Net Income figures are available to compare.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 832M | 2.22B | 647M | 407M | 226M |
| Depreciation & Amortization | 490M | 498M | 536M | 596M | 615M |
| Deferred Income Tax | 260M | 1.19B | 47M | (20M) | (15M) |
| Stock-Based Compensation | 0 | 0 | 0 | 0 | 0 |
| Change in Working Capital | (303M) | (723M) | 432M | 205M | (63M) |
| Accounts Receivables | (417M) | (261M) | 278M | 65M | (33M) |
| Inventory | (267M) | (527M) | 465M | (7M) | (210M) |
| Accounts Payables | 274M | (42M) | (101M) | 104M | 100M |
| Other Working Capital | 107M | 107M | (210M) | 43M | 80M |
| Other Non-Cash Items | (214M) | (1.05B) | (67M) | 175M | 191M |
| Operating Cash Flow | 1.07B | 2.13B | 1.6B | 1.36B | 954M |
| Capital Expenditures | (611M) | (747M) | (780M) | (713M) | (824M) |
| Acquisitions (Net) | (365M) | (18M) | 4M | (55M) | (11M) |
| Purchases of Investments | 0 | 0 | (88M) | 0 | (86M) |
| Sales of Investments | 0 | 0 | 0 | 56M | 0 |
| Other Investing Activities | 397M | 18M | 1M | 1M | (9M) |
| Investing Cash Flow | (579M) | (747M) | (863M) | (711M) | (930M) |
| Debt Repayment | 52M | (157M) | (228M) | (414M) | 213M |
| Common Stock Issued | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | (276M) | (1.17B) | (489M) | (308M) | (224M) |
| Other Financing Activities | (20M) | (93M) | 5M | (2M) | (67M) |
| Financing Cash Flow | (244M) | (1.42B) | (712M) | (724M) | (78M) |
| Effect of Forex Changes | 17M | (24M) | (17M) | (21M) | 18M |
| Net Change in Cash | 259M | (56M) | 3M | (93M) | (36M) |
| Free Cash Flow | 454M | 1.38B | 815M | 650M | 130M |
ICL Group Ltd
NYSE:ICL
Intrinsic Alpha fair value
Locked
Current Price
$4.19
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.